Company / EPS (Basic)
BioRestorative Therapies, Inc. EPS (Basic) History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$1.16
FY2025
5-year range
-$37.30 / -$1.16
FY2022-FY2025
Trend
+53.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Basic) has increased for 3 consecutive years, from $-37.30 in FY2022 to $-1.16 in FY2025.
Based on SEC 10-K filings.
-1.16 in FY2025.
Improved from $-5.11 to $-1.16 over the past 2 years.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- BioRestorative Therapies, Inc.'s eps (basic) has grown for 3 consecutive years.
- In FY2025, eps (basic) increased 53.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -47.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.16 | +53.0% |
| FY2024 | -$2.47 | +51.7% |
| FY2023 | -$5.11 | +86.3% |
| FY2022 | -$37.30 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026